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Profilaggrin is a large phosphorylated protein (ap-
proximately 400 kDa in humans) that is expressed in 
the granular cells of epidermis where it forms a major 
component of keratohyalin. It consists of multiple 
copies of similar filaggrin units plus amino- and 
carboxy-terminal domains that differ from filaggrin. 
Proteolytic processing of profilaggrin during termi-
nal differentiation results in the removal of these 
domains and generation of monomeric filaggrin 
units, which associate with keratin intermediate fila-
ments to form macrofibrils in the stratum corneum. 
The amino-terminal domain contains two calcium-
binding motifs similar to the EF-hands found in the 
S-100 family of calcium-binding proteins. In this 
report, we expressed the 293-residue amino-terminal 
pro-domain of human profilaggrin as a polyhistidine 
he program of differentiation that occurs in mamma-
lian epidermis involves the tightly controlled expres-
sion of a number of novel structural proteins in the 
spinous and granular cell layers before terminal dif-
ferentiation and formation of the stratum corneum. 
These proteins include the differentiation-specific keratins Kl and 
Kl0, involucrin, and cornifin (small proline-rich proteins), which 
are synthesized in spinous cells; and profilaggrin and loricrin, which 
are expressed in granular cells and form the major components of 
keratohyalin [1-3]. Profilaggrin is a highly phosphorylated protein 
consisting largely of multiple filaggrin repeats. It is processed 
during terminal differentiation of epidermal cells to form filaggrin 
units, which function in the lower stratum corneum to aggregate 
keratin intermediate filaments into tightly aligned bundles called 
macrofibrils. The processing of profilaggrin involves several en-
zymes that dephosphorylate and proteolytically cleave the protein 
to yield filaggrin [4 -7]. Finally, in the upper stratum corneum, 
filaggrin is degraded mostly into free amino acids, which are 
required for maintenance of epidermal osmolarity and flexibility 
[8,9]. 
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fusion protein in Escherichia coli, and characterized 
calcium binding by a 4SCa + + binding assay and fluo-
rescence emission spectroscopy. Fluorescence mea-
surements indicated that the profilaggrin polypep- , 
tide undergoes conformational changes upon the 
removal of Ca + + with ethylenediamine tetraacetic 
acid, demonstrating the presence of two calcium-
binding sites with affinities for calcium that differ 
ninefold (1.4 X 10- 4 M and 1.2 X 10-3 M). We suggest 
that this functional calcium-binding domain at the 
amino-terminus of human profilaggrin plays a role in 
profilaggrin processing and in other calcium-depen-
dent processes during terminal differentiation of the 
epidermis. K ey words: calcium-binding protein/epidermis/ 
fluorescence spectroscopy . ] Invest Dermatol 104:218-223, 
1995 
Sequencing of cDNA clones encoding mouse, rat, and human 
filaggrin repeats has shown that filaggrin is a histidine- rich , highly 
cationic protein that varies in size (e.g., m ouse, 26 kDa; hum an, 37 
kDa) and sequence among species [10-13]. However, the complete 
profilaggrin sequence derived from the human genomic DNA 
sequence revealed that the protein also contains sequences at the 
amino- and carboxy-termini of 293 and 157 amino acids, respec-
tively, which share little similarity with filaggrin [14,1 5]. The 
amino-terminus can be divided into two distinct domains , A and B. 
The first group of 81 amino acids (domain A) is hydrophobic and 
contains two putative calcium-binding motifs similar to the EF-
hands of the S-100 family of proteins. Domain B is 212 amino acids 
and is highly hydrophilic. Like other genes belonging to the S-100 
family, profilaggrin contains two introns, one between the EF-
hands and a second in the :; I non-coding region. In addition, 
profilaggrin has been mapped to human chromosome l q21 [1 3] , 
where a number of other genes belonging to the S-100 EF-hand 
family also have been localized, including calcyclin, calgranulins A 
and B, and trichohyalin [16 - 19]. This region of chromosome lq 
also contains a number of other epidermally expressed genes, 
including loricrin, involucrin, and the small proline-rich proteins 
([17,19,20] and references therein). The domain-A protein se-
quences predicted from the cDNA sequence show greater than 90% 
identity among rat, mouse, and human profilaggrin (RBP, unpub-
lished observations), in contrast to the amino acid sequence for the 
filaggrin repeat unit (42% to 60% identity [11]). This suggests that 
the EF-hand domain is functionally important. 
Calcium is required at high intracellular levels (0 .1- 0.5 mM) for 
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the expression of all known genes that encode differentiation-
specific structural proteins, including keratins Kl and Kl0, pro-
filaggrin, and loricrin [21-23]. Calcium also activates a number of 
enzymes in terminally differentiating epidermal cells, including a 
protease involved in processing profilaggrin to filaggrin [7] and 
epidermal transglutaminase(s), which cross-links a number of struc-
tural epidermal proteins into the cornified cell envelope [24-26]. 
This program of gene expression and some other events that occur 
during terminal differentiation are coordinated in part by a calcium 
gradient in the epidermis, whereby intracellular calcium concen-
trations increase from basal to granular cells [27,28]. The identifi-
cation of a potential calcium-binding domain in profilaggrin sug-
gests that calcium might regulate the expression of this protein or its 
processing in a calcium-dependent manner [7]. 
To determine whether the EF-hand domain of human profilag-
grin binds calcium, as predicted from sequence comparisons with 
known S-100 proteins, we analyzed the calcium-binding properties 
of the amino-terminal domain expressed in Escherichia coli by both 
45Ca + + slot blot hybridization and fluorescence emission spectros-
copy. We demonstrate that both EF-hands bind calcium with 
different affinities, in a manner analogous to that reported for other 
S-100 proteins. 
MATERIALS AND METHODS 
Construction of pET Expression Plasmid A polymerase chain re-
action approach was used to generate a fragment containing the first 
293 amino acids of human profilaggrin using the oligonucleotides 
5' CCCCAT ATGTCT ACTCTCCTGGAAAACATC 3' and 5' CCC.c.TI:C 
GAGACGCTT -TCTTGTCCTGGACTCCTG 3'. The oligonucleotides 
include Nde I and Xho I restriction sites (underlined) for cloning; the Nde 
I site also includes a translation initiation codon. Polymerase chain reaction 
was performed for 30 cycles of 1 min at 94°C, 2 min at 55°C, and 2 min at 
noc in a Coy Tempcycler with a cDNA clone that contained the first 403 
amino acids of human profilaggrin as template [14]. The PCR product (890 
bp) was gel purified, digested with Nde I and Xho I, and cloned into 
pET22b (Novagen, Madison, WI), a plasmid that includes a stretch of six 
histidines at the carboxy-terminal end of the encoded recombinant protein. 
The DNA sequence was verified by dideoxy sequencing of both strands 
using a Sequenase 2.0 kit (U.S . Biochemical Corp., Cleveland, OH) and 
[a-35S]dATP. 
Expression of the Amino-Terminal Domain of Human Profilaggrin 
in E. coli and Purification by Nickel-Chelate Affinity Chromatog-
raphy The construct was transformed into E. coli BL21 (DE3), and a 
single colony was grown in 5 ml L-broth containing 50 /Lg/ml carbenicillin 
for 4-6 h. This culture was diluted 1:50 into fresh L-broth, and the bacteria 
were grown at 37°C until the A600 reached 0.6 - 0.8 . Isopropyl-J3-D-
thiogalactopyranoside was added to 1 mM to induce expression of the 
profilaggrin-polyhistidine recombinant protein (denoted proFG293-his), 
and the bacteria were grown for a further 3 h . The cells were harvested by 
centrifugation, washed once in cold nickel column binding buffer (5 mM 
imidazole, 0.5 M NaCl, 20 mM Tris/HC1, pH 7.9), and resuspended in 2 ml 
binding buffer. The mixture was sonicated for 5 min on ice and then 
centrifuged at 27,000 X g for 45 min at 4°C . The pellet, containing the 
inclusion bodies, was resuspended in 2 ml binding buffer that contained 8.8 
M urea and 10 /Lg/ml phenylmethylsulfonylfluoride. After homogenization 
by several strokes in a Duall ground glass homogenizer, the slurry was 
diluted with 2 ml of urea buffer and left at room temperature for 30 min. 
The insoluble material was removed by centrifugation. After overnight 
dialysis at 4°C against binding buffer that contained 6 M urea, the 
supernatant was passed through a 2-ml nickel-chelate affinity resin (Nova-
gen), which had been prepared according to the manufacturer's directions. 
The protein was renatured on the column by stepwise reduction of the urea 
concentration from 6 M to 0 M in I-M increments of 5 ml [29]. The bound 
protein then was eluted in buffer containing 100, 200, and 300 mM 
imidazole in I-ml fractions (see Fig 1). Protein concentration was deter-
mined by absorbance at 280 nm and by densitometric scanning of a 
Coomassie Brilliant Blue R250-stained polyacrylamide gel. The signal 
obtained with the recombinant protein was compared to the signal of 
known concentrations of pre stained standards (Life Technologies, Gaith-
ersburg, MD). Typically, a 500-ml culture yielded 400-500 /Lg of the 
proFG293-his recombinant protein. 
As a control for Ca + + binding, the his-lac Z (J3-galactosidase-polyhisti-
dine) protein was expressed from a pET-14b construct (provided by 
Novagen) and purified according to the manufacturer's directions. 
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Gel Electrophoresis and Immunoblotting Proteins were separated in 
7.5% to 12.5% gradient slab sodium dodecylsulfate-polyacrylamide gels 
[30]. For irnmunoblotting, proteins were resolved on gels and transferred 
electrophoretically to nitrocellulose (0.45 /Lm; Schleicher & Schuell, Keene, 
NH) for 12 h at 100 mAo Immunoreactive proteins were visualized with the 
avidin-biotin-peroxidase method [31]. The proFG293-his protein was de-
tected with a polyclonal antibody prepared against a synthetic peptide 
corresponding to amino acids 16-30 of the human profilaggrin sequence, 
which represents part of the first EF-hand (denoted EF-Ab). This antibody 
reacts with human profilaggrin on Western blots and stains granular cells of 
epidermis that express profilaggrin (RBP, ]RK, and BAD, unpublished 
results) . 
4Sea + + Binding Assay Calcium-binding assays were performed on 
proteins bound to PVDF (polyvinylidene fluoride) membrane (Immobilon 
P, Millipore, Bedford, MA), as described [15]. Typically, the slot blots were 
incubated with 15 ml of 50 mM Tris/HCI, pH 7.5, containing 100 mM 
NaCl, 10 /LM CaCI2, and 10 /LCilml of 45CaCl2 (73 rnBq/ml; Amersham, 
Arlington Heights, IL), for 1 h. The filters were washed as described and 
exposed to Hyperfilm x-ray film (Amersham) for 1-3 d with an intensifying 
screen. The radioactivity bound to the filters was quantified using a 
Phosphorimager Model 400S equipped with ImageQuant software (Molec-
ular Dynamics, Sunnyvale , CA) . 
Fluorescence Emission Spectroscopy The proFG293-his protein (400 
/Lg) was saturated with calcium by incubation with 20 mM CaCl2 for 30 min 
at room temperature. Free and protein-bound calcium were separated by 
size exclusion chromatography on Bio-Gel P-6DG resin (Eeeno-Pac 10DG 
column, Bio-Rad Laboratories, Hercules, CA) using buffered Tris-saline (50 
mM Tris-HCI, pH 8.0, 0.15 M NaCl) as the eluent. The calcium-enriched 
recombinant protein then was aliquoted into tubes that contained varying 
concentrations of ethylenediamine tetraacetic acid (EDT A) in Tris-saline 
(see Results). This approach was used as an alternative to dialysis, as we 
found that the proFG293-his recombinant protein adhered tighdy to dialysis 
tubing. 
Intrinsic fluorescence measurements were performed at room tempera-
ture in a Perkin-Elmer LS-50B luminescence spectrometer controlled by 
FLDM software operating on a DEC 386SX computer. The emission 
spectra (330 -500 nm) of protein or blank solutions were collected at 800 
nm/min after excitation at 290 nm with a slit width of 20 nm. The 
excitation wavelength (290 nm) was chosen so as to give optimal separation 
between endogenous Rayleigh scattering and the emission spectra of the 
recombinant protein. The spectra of solutions that contained no peptide 
were subtracted from the spectra of solutions that contained peptide. The 
peak height at 390 nm of each spectrum was determined and used to 
calculate the percent change in fluorescence intensity (FI) from a control 
sample of protein that contained no EDT A, according to the following 
formula: 
[(FI sample + EDTA) - (FI sample - EDTA)] 
----------------- X 100 
(FI sample - EDTA) 
= % change in fluorescence. 
Saturated solutions of tyrosine and tryptophan amino acids in Tris-saline 
were diluted with Tris-saline until the intensity of their fluorescence 
emission was within the scale observed for 40 /Lg of the proFG293-his 
protein. A saturated solution of phenylalanine in Tris-saline was used 
undiluted. 
RESULTS 
Expression of the Human Profilaggrin Amino-Terminal 
Domain in E. coli To determine whether the EF-hand region of 
profilaggrin binds calcium, we expressed the first 293 amino acids 
in E. coli as a profilaggrin-polyhistidine fusion protein. Both strands 
of the expression construct were sequenced to verify that the 
correct sequence, reported previously [14], had been cloned. 
Expression of the recombinant protein (denoted as proFG293-his) 
was induced with isopropyl-I3-D-thiogalactopyranoside, and it was 
purified by nickel-chelate affinity chromatography. Purification of 
proFG293-his was followed by sodium dodecylsulfate-polyacryl-
amide gel electrophoresis and immunoblot analysis with an anti-
body to part of the first EF-hand (EF-Ab) (Fig 1). The results show 
that the recombinant protein displayed an electrophoretic mobility 
in agreement with the predicted molecular weight of 36 kDa. As 
expected, most of the endogenous bacterial proteins did not bind to 
the nickel-chelate resin or were eluted at low (20-100 mM) 
220 PRESLAND ET AL 
A B 
12345 6 123 456 
kD 
70-
44-
28-
18-
Figure 1. Purification of the proFG293-his fusion protein from E. 
coli. Expression of the proFG293-his protein (cloned into pET-22b and 
transformed into E. coli BL21 [DE3]) was induced with isopropyl-B-D-
thiogalactopycanoside. The protein was extracted and affinity purified by 
nickel-chelate chromatography. A) Commassie-blue-stained 7.5% to 12.5% 
sodium dodecylsulfate-polyacrylamide gel of the purification. B) Immuno-
blot analysis using the amino-terminal EF-Ab antibody. Lane 1, total 
bacterial extract; lane, unbound (flow-through) fraction in 5 mM imidazole; 
lane 3, proteins eluted in 20 mM imidazole; lane 4, proteins eluted at 100 
mM imidazole; lanes 5, 6, proFG293-his fusion protein eluted at 200 mM 
imidazole (arrow). Note (in B) that some proFG293-his protein does not 
bind to the column (lane 2) , and a significant amount of protein is eluted at 
100 mM imidazole (lane 4) along with some lower-molecular-weight 
proteins. The fraction eluting at 200 mM imidazole is greater than 90% pure 
(lane 6) and was used for the calcium-binding studies. 
concentrations of imidazole (Fig 1, lanes 2-4). Some proFG293-his 
protein eluted from the column at 100 mM imidazole (Fig lB, lane 
4). However, the bulk of the recombinant protein eluted at 
200-300 mM imidazole and was estimated to be at least 90% pure 
(Fig lA, lanes 5,6, and data not shown). The proFG293-his protein 
eluted in buffer that contained 200 and 300 mM imidazole (Fig lA, 
lane 6) was used for the calcium-binding studies. 
The Recombinant Amino-Terminal Fragment of Human 
Profilaggrin Binds 4SCa + + For the slot blot analysis with 
4SCa + + , equal amounts of the purified proFG293-his protein, yeast 
calmodulin (which has three functional EF-hands [32]), and the 
control proteins lysozyme, bovine serum albumin, and the {3-ga-
lactosidase-polyhistidine fusion protein were bound to PVDF mem-
brane and incubated with a solution containing 4SCa + + . The results 
(Fig 2) demonstrate that the proFG293-his recombinant protein 
binds calcium, as does yeast calmodulin, whereas the other pro-
teins, including {3-galactosidase-polyhistidine, do not bind Ca + + . 
Quantitation of the amount of 4SCa + + bound (Fig 2B) indicated 
that compared to yeast calmodulin, which binds 3 mol of calcium 
ions to 1 mol of protein [32], the recombinant profilaggrin protein 
binds an average of 1.5 mol of calcium per mol of protein (average 
of two independent experiments). These results indicate that at 
least one of the two EF hands functions to bind calcium in this 
assay. 
Analysis of Calcium Binding by Fluorescence Emission 
Spectroscopy The binding of calcium to the recombinant 
pro293-his protein was analyzed further by fluorescence emission 
spectroscopy [33]. This assay detects changes in the fluorescence of 
aromatic amino acids upon the removal of bound calcium and is 
therefore an indirect measure of change in the conformational state 
of the protein. The recombinant protein contains a total of 19 
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Figure 2. The proFG 293 -his fusion protein binds 45 Ca + +. A) Thirty 
micrograms of each protein was immobilized onto PVDF membrane and 
incubated with 4SCa + + as described in Materials and Methods. B) Quantita-
tion of the amount of radioactivity bound to the membrane (shown in A) by 
PhosphorImager analysis. From the amounts of yeast calmodulin (1.9 pmol) 
and proFG293-his (0.9 pmol) bound to the membrane, it was calculated 
that, compared to yeast calmodulin, which binds 3 Ca ++ per molecule [32] 
(22 relative PhosphorImager units/pmol) , proFG293-his binds 1.5 Ca ++ 
per molecule (11 relative PhosphorImager units/pmol). The proteins shown 
are CAM, yeast calmodulin; LacZ, {3-galactosidase-polyhistidine protein; 
BSA, bovine serum albumin; Lys, lysozyme; proFG, the proFG293-his 
recombinant protein. 
aromatic amino acids (11 tyro sines [Tyr] , seven phenylalanines 
[Phe], and one tryptophan [Trp]) that are capable of fluorescence 
emission in response to ultraviolet light (Fig 3). A number of these 
Tyr and Phe residues are located in and around the two EF-hand 
domains. 
Intrinsic Fluorescence Emission Spectra of proFG293-his Are Due to a 
Number of Aromatic Amino Acids: We first compared the fluores-
cence spectra of the recombinant protein with solutions of the 
aromatic amino acids Trp, Tyr, and Phe after excitation at 290 nm. 
As shown in Fig 4, all three amino acids are capable of emission at 
wavelengths similar to that observed for the recombinant protein. 
A saturated solution of Phe was used to generate a signal of 
sufficient intensity for detection, whereas dilute solutions of Trp 
and Tyr were used. Phe is only weakly fluorescent compared to Trp 
or Tyr and is not detected readily in isolated protein preparations 
[34,35], a result confirmed in this study (Fig 4). By comparing the 
MSTLLENIFA IINLFKQYSK KDKNTDILSK KELKELLEKE 40 
FRQILKNPDD PDMVDVFMDH LDI!:lHNKKID FTEFLkWFK 80 
i.AQAYYESTR KENLPISGHK HRKHSHHDKH EDNKQEENKE 120 
NRKRPSSLER RNNRKG~~KGR SKSPRETGGK RHESSSEKKE 160 
RKGYSPTHRE EEYG K:Nlll-o::N S SKKEKNKTEN TRLGDNRKRL 200 
SERLEEKEDN EEGVYDYENT GRMTQKWIQS GHIATYYTIQ 240 
DEAYDTTDSL LEENKlYERS RSSDGKSSSQ VNRSRHENTS 280 
QVPLQESRTR KRR hhb..hhh 299 
Figure 3. Sequence of the amino-terminal domain of human 
profilaggrin contained in !:he profilaggrin-polyhistidine recombi-
nant protein. The two EF-hands are underlined, and the aromatic amino 
acids are shown in bold. The single tryptophan residue is located at residue 
227. The polyhistidine tag at the carboxy-terminus is shown in lowercase. 
The sequence is described elsewhere [14]. 
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Figure 4. Emission spectra o f aromatic amino acids and the 
proF G 293-his r e combinant p rotein. Measurements were performed in 
50 mM Tris-HCI, pH 8.0, 0.15 M NaCI at an excitation wavelength of290 
nm. Slit widths were 15 nm for excitation and 20 nm for emission. The raw 
spectra are shown and are not corrected for the contribution of the Raman 
spectra of water. Phenylalanine was used as a saturated solution. 
emission intensities and maxima of the three aromatic amino acids 
with that of the proFG293-his recombinant protein (Fig 4), we 
attributed the fluorescence emission spectra of the recombinant 
protein to a composite of signals from the Tyr and Trp residues in 
the protein, because these residues fluoresce 18- and 200-fold as 
much as Phe [34,35]. 
Intensity of Fluorescence of proFG293-his Is Concentration-Dependent: 
Figure 5 shows the intrinsic fluorescence emission spectra of the 
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Figure 5. Intensity of fluorescence emission of proFG293-his is 
proportional to protein concentration. Measurements were performed 
after excitation at 290 nm as described in Fig 4 (see also Materials and 
Methods). Shown are corrected spectra after subtraction of the spectrum 
contributed from buffer alone. The values above each spectrum represent 
the protein concentration in fLg/ml. The peak height at 390 nm was 
determined at each protein concentration (see inset). 
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fusion protein at 390 nm as a function of protein concentration, 
which demonstrates that the peak height is proportional to the 
amount of protein in solution. We therefore selected 15 /Lg/ml as 
the working concentration of protein for further characterization of 
calcium binding; this value is within the linear range of the assay. 
ProFG293-his Undergoes Conformational Changers) Upon Removal of 
Bound Ca + + : In preliminary experiments, we tested the recom-
binant protein for its ability to interact with Ca + + by measuring the 
change in intrinsic fluorescence upon addition of calcium. The 
addition of calcium to proFG293-his resulted in a substantial 
increase in fluort::scence emission at 390 nm (data not shown). This 
indicated that the protein's calcium-binding sites were not occupied 
fully upon isolation from E. coli. We therefore saturated the 
recombinant protein with calcium, removed the free calcium by 
size exclusion chromatography, and then determined the change in 
fluorescence intensity that resulted from the addition of increasing 
concentrations of EDT A (Fig 6). A dose-dependent decrease in 
peak height at 390 nm (represented in Fig 6 by a percent change in 
fluorescence intensity) was observed between 12.5 /LM and 20 mM 
EDTA (PEDTA 4.9-1.7). From these data, it is possible to identify 
the existence of two sets of calcium-binding sites on the protein at 
pH 8.0, as indicated by the two transitions in the EDT A titration 
curve. EDTA concentrations of 40 and 350 /LM are required to 
produce 50% of the maximal change in fluorescence intensity for 
each of the two transitions (Fig 6). From these data, we calculate 
that the KdS of the two EF-hands for Ca + + are 1.2-1. 6 X 10- 4 M 
and 1.1-1.4 X 10- 3 M, assuming that three to four molecules of 
Ca + + are removed by one molecule of EDT A. 
DISCUSSION 
Profilaggrin is a major protein component of the keratohyalin 
present in the granular layer of epidermis. It is a member of the 
S-100 family of calcium-binding proteins and contains two EF-
hands at its amino terminus. In this paper, we show by two methods 
that the amino-terminal domain of human profilaggrin, expressed 
in E. coli and purified by nickel-chelate affinity chromatography, 
binds calcium. Furthermore, the fluorescence data demonstrate that 
both EF-hands can act as Ca + + -binding loops. This confirms and 
extends a previous report [15], which showed calcium binding to 
mouse profilaggrin immobilized on PVDF membrane. 
Fluorescence emission spectroscopy allows detection of changes 
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Figure 6. Loss of calcium from the proFG293-his fusion protein 
causes conformational changes. The figure shows the percent change 
in intrinsic fluorescence intensity at 390 nm of proFG293-his as a function 
of increasing EDTA concentration. The sample was prepared as described in 
Materials and Methods. Measurements were performed as in Fig 4. Note the 
two transitions in the fluorescence spectrum, indicative of two conforma-
tional changes in the protein. 
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in the fluorescence of aromatic amino acids in a protein and 
provides evidence of conformational changes. In this study, we 
demonstrated that the recombinant profilaggrin polypeptide under-
goes conformational changes upon releasing calcium (Fig 6). From 
the fluorescence emission wavelength, and because there is no shift 
in the emission maximum in response to addition of EDT A, we 
conclude that the contribution of Phe to the fluorescence emission 
signal of proFG293-his is negligible and that the fluorescence 
observed is due to multiple Trp and Tyr residues in the protein. The 
removal of bound calcium by titration with EDT A leads to a large 
reduction in fluorescence emission (Fig 6), suggesting that the Trp 
(and at least some of the Tyr) residues in the protein subsequently 
become less accessible to the aqueous environment. The data 
demonstrate two distinct shifts in fluorescence, indicating loss of 
calcium from the high- and low-affinity calcium-binding sites in the 
profilaggrin amino-terminus, with estimated KdS for Ca + + of 1.4 X 
10-4 M and 1.2 X 10- 3 M, respectively. Similar observations have 
been made with S-100a and S-100b proteins [36-38], whereby the 
S-100 proteins undergo conformational changes upon binding 
calcium. 
We did not test the capacity of other divalent cations to bind to 
the recombinant profilaggrin protein. However, previous studies 
have shown that the affinity of EF-hand sites for magnesium is 
lower than for calcium by three to four orders of magnitude in the 
calcium-binding proteins S-100b [38], parvalbumin [39], and 
SPARC (osteonectin) [40]. Thus, these proteins do not bind 
magnesium at physiologic concentrations. Zinc also binds with high 
affinity to some S-100 proteins, but at a histidine-rich site distinct 
from the EF-hands that bind calcium [41]. 
Several lines of evidence have shown that calcium is a critical 
regulator of epidermal differentiation. It is required at levels above 
the concentrations present in serum for transcription of late differ-
entiation markers such as profilaggrin and loricrin [21]. In addition, 
calcium regulates the activity of certain enzymes in cornifying cells, 
such as the second-stage protease, which processes profilaggrin 
intermediates to filaggrin [7]; and epidermal transglutaminase, 
which cross-links loricrin, involucrin, and other proteins into the 
cornified cell envelope [24-26]. The high concentration of calcium 
present in granular cells [27,28] suggests that, in vivo, the EF-hand 
domain of profilaggrin is likely to be saturated with calcium as 
keratohyalin accumulates in granular cells. Additional calcium may 
bind to profilaggrin deposited in keratohyalin via the many phos-
phoserine residues known to be present in each filaggrin repeat 
[42,43]. That profilaggrin does bind calcium in vivo is suggested by 
recent studies with the dye alizarin red S, a calcium-complexing 
dye, which showed a strong staining of the keratohyalin granules 
and adjacent most proximal layer of the stratum corneum of rat 
epidermis (R. Thieroff-Ekerdt, personal communication). This 
same localization is shown by both immunohistochemistry and 
immunoelectron microscopy with the profilaggrin EF-hand anti-
body, indicating that this domain is present in cells where free 
calcium is concentrated (our unpublished observations). 
What is the function of the calcium-binding domain in profilag-
grin? We have suggested previously [14] that it functions in 
transition cells to bind calcium that is necessary for profilaggrin 
processing during terminal differentiation, or it may regulate 
mRNA expression by feedback inhibition of profilaggrin transcrip-
tion, or it may function in the granular layer to assist in the 
translation of profilaggrin and the formation of keratohyalin. 
During processing of profilaggrin to filaggrin, the calcium-binding 
domain apparently is cleaved from the filaggrin sequences and may 
function independently [6,7]. The high degree of sequence conser-
vation of the calcium-binding domain between human, rat, and 
mouse profilaggrin (RBP, unpublished observations) and the con-
servation of this EF-hand motif in the related intermediate-fila-
ment-associated protein trichohyalin, a protein marker of the inner 
root sheath and medulla cells of hair follicles [44 - 46], suggest an 
important function for this motif. This similarity contrasts with the 
variability of filaggrin sequences between species, which differ in 
both length and amino acid sequence [11]. Our studies here 
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characterize the calcium binding to this region and demonstratl 
that it has binding properties analogous to other S-100 proteins 
These results suggest that this domain is significant in this biologi. 
environment where calcium is essential. Future studies both in vitYI' 
and in vivo will be aimed at identifying the function of thi : 
important domain in profilaggrin. 
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ANNOUNCEMENT 
The European Society of Dermatological Research Clinically Oriented Symposium, "Vitamin 
D: Actions and Applications in Dermatology" will be held April 27-29, 1995 in Aarhus, 
Denmark. 
The international symposium is intended to bring together investigators interested in both 
basic science and clinical medicine. The program will include invited speakers for introductory 
lectures as well as free communications (oral and poster presentations). Selected papers from 
the symposium will be published in the Journal of Investigative Dermatology. 
The program will include the biology of vitamin D; expression, regulation, and gene 
regulation of the vitamin D receptor; photobiology of Vitamin D, role of cytokines and growth 
factors; immunomodulatory role (lymphocytes, macrophages, Langerhans cells); cell differen-
tiation and photobiology; clinical experience with vitamin D analogs; clinical tolerability and 
safety; and potential use in lymphomas and carcinomas. 
The organizing secretariat includes Knud Kragballe (Denmark), Thomas Krieg (Germany), 
Karsten Fogh (Denmark), Christian Gmnh0j Larsen (Denmark), John J. Voorhees (USA), 
Jean-Hilaire Saurat (Switzerland), Daniel Bikle (USA), Peter van de Kerkhof (The Nether-
lands), Michael Holick (USA), and Klaus Bendtsen (Denmark). 
For information contact Knud Kragballe, MD, PhD, Department of Dermatology, Marselis-
borg Hospital, DK-8000 Aarhus C, Denmark. Tel. +45 89 49 18 56; Fax +45 89 49 18 70. 
